Unicycive Therapeutics, Inc.
USD5.69
+0.24 (+4.40%)
CEO
Shalabh K. Gupta
IPO Date
2021-07-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.53
Prev. Close
$5.45
Day Low
$5.41
Day High
$5.87
52W Low
$3.71
52W High
$8.74
Market Cap
$0.12B
Volume
1.13M
| 84,200 |
| $0.00 |
| 21 May 2026 | Kenkare-Mitra Sara | director | A-Award | Acquired | 42,100 | $0.00 |
| 20 May 2026 | Jermasek Douglas | EVP, Corporate Strategy | A-Award | Acquired | 169,500 | $0.00 |
| 20 May 2026 | Gupta Pramod | EVP, Pharmaceuticals and BD | A-Award | Acquired | 169,500 | $0.00 |
| 20 May 2026 | Townsend John | CFO | A-Award | Acquired | 169,500 | $0.00 |
| 18 May 2026 | Laumas Sandeep | director | A-Award | Acquired | 84,200 | $0.00 |
| 18 May 2026 | Laumas Sandeep | director | A-Award | Acquired | 42,100 | $0.00 |
| 26 Aug 2025 | Aggarwal Gaurav | director | C-Conversion | Acquired | 652,900 | $0.00 |
| 26 Aug 2025 | Aggarwal Gaurav | director | D-Return | Disposed | 3,199.21 | $4.90 |